Niraj Cement Structurals Ltd (NCSL)

Period 

26-May to 30-May 2008

Size (Equity Shares)

32,50,000

Type 

100% Book Building

Face Value 

Rs. 10- 

Price Range 

Rs 175 to Rs 190

Market Lot 

30

Max shares Retails investor can apply at cut off

510

Registrar 

Intime Spectrum Registry Ltd

Registrar’s email 

ncsl@intimespectrum.com

Lead Manager 

Allbank Finance Limited

Listing 

BSE

Grading 

About the company 

Incorporated : 1998, Engaged in the infrastructure development, building roads, airport upgradation, bridges, airport runways, pavements, industrial structures, ready mix concrete and others. The company is operating from Mumbai and at present executing project in Orissa and Maharashtra.

NCSL’s have a fleet of construction equipment.

The list of projects completed by company: Worli Bandra Sea Link Package-III, Apron Flooring in connection with Construction of Air India Hanger Project, Mumbai; Dry Lean Concrete & Pavement Quality with Slip Form Paver at Part Kon to Kalamboli; Replacement of existing concrete pavement (apron) panels in front of Air India Hanger No. 1 & 2 at Old Airport; New Fire Station at Mumbai Airport Mumbai, SH Rigid Pavement; Execution of Track linking works in between Tomka-Keonjhar on E.C. Railway.

Under execution: Widening to 4/6 lanes and strengthening of existing 2 lane carriageway of NH-60 in the state of Orissa, LBS Marg from Sion to Kanjurmarg & Kanjurmarg to Mulund Check Naka; Dam & Spilway under Tuirial Hydro Electric Power Station Project Mizoram; Strengthening and Extension of Container Yard at NMPT With Paver Blocks; Providing Heavy Duty Pavement in Mangalore; Providing Paver Block Pavement at Main Gate, KK Gate and Seamen’s Circle Junction in the Wharf Area in Mangalore etc.

Objects of the Issue

Investment in capital equipment;

Funding long term working capital requirements;

To meet expenses of the Issue in order to achieve the benefits of listing on the Stock Exchanges;

General corporate purposes.

Bafna Pharmaceuticals Ltd

Period 

27-May to 30-May 2008

Size (Equity Shares)

Type 

Fixed Price Issue

Face Value 

Rs. 10- 

Price Range 

Rs 40 to Rs 40

Market Lot 

Max shares Retails investor can apply at cut off

Registrar 

Cameo Corporate Services Ltd

Registrar’s email 

cameo@cameoindia.com

Lead Manager 

Keynote Corporate Services Ltd, Ashika Capital Ltd

Listing 

BSE

Grading 

About the company 

Incorporated: 1995, Engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products. Manufactures 126 formulations under various therapeutic segments, such as anti-infective, cholesterol lowering agents, analgesic and antipyretic, antihelmintics, appetite stimulants, cough and cold preparations, antiulcerants anti diabetic, and vitamins.

In 2006, Bafna has set up an 100% EOU unit at Madhavaram for the production of tablets and capsule with a capacity of 6973.20 lacs and 2462.40 lacs. The unit has been WHO GMP certified and also ISO 9000 certified. The products manufactured in this factory caters to the markets of Srilanka, Ghana and Ukraine. Bafna was involved in the execution of contracts for the generic division of M/s. Croslands from the period 1994 to 2001. Bafna was awarded the WHO GMP certification during the year 1995. Presently around 57 products of the company are registered in Srilanka, 4 products in Ukraine, 1 product in Ghana. The company received the Best Supplier award from the Srilankan Government during 2005.

Objects of the Issue

To undertake Brand Building exercise in domestic & international markets;

To part finance the cost of obtaining MHRA approval for Grantlyon unit;

To set up a Research & Development unit at Grantlyon;

To repay high cost debt;

To meet the working capital requirement;

To meet expenses of the Issue in order to achieve the benefits of listing on the Stock Exchanges;

General corporate purposes.